Market Currents
Alexion Pharmaceuticals (ALXN +4.3%) trades higher after its Q4 beat estimates across the board...
-
Thursday, February 9, 2012, 2:37 PM ETAlexion Pharmaceuticals (ALXN +4.3%) trades higher after its Q4 beat estimates across the board earlier today. Revenue jumped 45% Y/Y on higher overall net product sales, particularly in its blood disease drug Soliris with new PNH patients.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
